William C. Hahn, M.D., Ph.D.
Dr. William (Bill) C. Hahn currently serves as an Advisor to MPM BioImpact. Bill is a leading scientist and physician involved in biomedical research and in the care of cancer patients. He is currently Chief Research Strategy Officer and Chief, Division of Molecular and Cellular Oncology at Dana-Farber Cancer Institute and is also an Institute Member of the Broad Institute.
Bill’s numerous groundbreaking discoveries have informed the current molecular understanding of cancer and have defined the tools, technologies and experimental models used to discover and validate targeted cancer therapies. Widely recognized for his work, he was honored with the 2015 Richard and Hinda Rosenthal Award from AACR and the Ho-Am Prize in Medicine in 2010.
He serves as a medical oncologist and Professor at the Dana-Farber Cancer Institute and Harvard Medical School and is an Institute Member of the Broad Institute of MIT and Harvard. He is also the Chief Research Strategy Officer and the Chief of the Division of Molecular and Cellular Oncology in the Department of Medical Oncology at Dana-Farber Cancer Institute.
Of his many other awards and professional affiliations, Bill received the Wilson S. Stone Award from M.D. Anderson Cancer Center for outstanding research in cancer and the Howard Temin Award from the National Cancer Institute; he has also served as President of the American Society for Clinical Investigation and was elected to the Association of American Physicians.
Bill earned his M.D. and Ph.D. from Harvard Medical School and his B.A. from Harvard University. He completed clinical training in internal medicine at Massachusetts General Hospital and medical oncology at Dana-Farber and conducted his postdoctoral studies in the lab of Robert Weinberg at the Whitehead Institute for Biomedical Research.